Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification
- Author:
Yanhua BAI
1
;
Kennichi KAKUDO
;
Chan Kwon JUNG
Author Information
- Publication Type:Review Article
- From:Endocrinology and Metabolism 2020;35(4):696-715
- CountryRepublic of Korea
- Language:English
- Abstract: Advances in medical sciences and evidence-based medicine have led to momentous changes in classification and management of thyroid neoplasms. Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers. The new 2017 World Health Organization (WHO) classification of thyroid neoplasms updated the diagnostic criteria and molecular and genetic characteristics reflecting the biology and behavior of the tumors, and newly introduced the category of borderline malignancy or uncertain malignant potential. Some neoplasms were subclassified, renamed, or redefined as a specific entity. This review introduces changes in the fourth edition WHO classification of thyroid tumors and updates the contemporary diagnosis and classification of thyroid tumors. We also discuss several challenges with the proposal of new diagnostic entities, since they have unique histopathologic and molecular features and clinical relevance.
